O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer

O-091 A randomized phase II trial of docetaxel alone and in combinationwith gefitinib (IRESSA) as second-line therapy for patients with non-small-cell lung cancer

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Vol. 49; p. S33
Main Authors: Robinet, G., Falchero, L., Perol, M., Thomas, P., Monnet, I., Grivaux, M., Crequit, J., Letreut, J., Paillotin, D., Chouaid, C.
Format: Journal Article
Language:English
Published: Elsevier Ireland Ltd 01-07-2005
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(05)80225-9